Antipodes Partners awarded

2026 Fund Manager of the Year, Australia

Morningstar Awards 2026 © Morningstar, Inc. All Rights Reserved.

Finding value among global cyclicals

Investors should tread carefully amid uncertainty over US interest rates.

With US inflation proving stickier than expected, investors may be disappointed by the pace of monetary easing. Although our global portfolios retain a defensive posture, we’re finding opportunities among carefully selected cyclicals.

The market assumes that even if the world’s largest economy doesn’t achieve the perfect landing, the Fed has scope to prevent a hard landing – the worst-case scenario has been averted. This is one possible outcome, but we see greater uncertainty ahead with risks around an inflation wall and the lagged ramifications of tight monetary policy.

The pathway for inflation is down, but we see core inflation remaining stickier than the market expects, and, while we’ve likely seen the peak of the tightening cycle, there is a risk the market will be disappointed by the pace of loosening. In our view, investors need to be open to the idea that rates could remain higher for longer.  And while the US economy has remained resilient to date, the threat posed by monetary tightening may not have passed. We’re watching the labour market, which is showing signs of loosening and the pace of nominal wage growth. 

As a result, the global portfolios retain their relatively defensive tilt. However, the weak industrial production cycle – reflecting the slowdown in manufacturing as consumers pivoted away from goods and towards services – has provided an opportunity to selectively add to global cyclicals.

We favour those stocks that have attractive supply-and-demand dynamics, are in sectors that are showing signs of reaching the bottom of the cycle and are priced on low multiples.

Examples include Oil/Natural gas companies Total Energies and Occidental Petroleum. To find out more about why we like these two stocks, read Oil: the market on a knife edge.

There are further examples in global chemicals, pulp and paper and potash. Stocks we favour in the latter category include LyondellBasell, a chemicals business with feedstock flexibility that is gaining from industrial and consumer supply chain trends. The low-cost Brazilian pulp and paper producer Suzano is another stock we like in this area. It benefits from favourable supply/demand dynamics on account of low prices, underinvestment, land shortages, and regulatory barriers to entry. Potash is another favoured sector as demand rises globally to support farm yields.

We also continue to find mispriced beneficiaries of investment in energy transition, supply chain onshoring and Cloud/AI monetisation. Around a third of our global portfolios are exposed to these investment themes, and during the recent quarter we added to our exposure to hardware stocks – for example TSMC. The Taiwanese chipmaker is a key enabler of artificial intelligence (AI) and is prioritising return on capital employed as it harvests investments made in Taiwan, Japan and the US.

If it becomes apparent that the Federal Reserve can cut interest rates and the economic backdrop remains resilient, we will lean further into our cyclical exposures.

Read our Quarterly Report for greater insight into our market outlook, strategy and performance.


 

Subscribe to receive the latest news and insights from Antipodes

 


IMPORTANT INFORMATION:
All content in respect of the Antipodes Global Shares (Quoted Managed Fund) (ARSN 625 560 269), the Antipodes Global Fund – Long (ARSN 118 075 764), the Antipodes Global Fund (ARSN 087 719 515), and the Antipodes Emerging Markets (Managed Fund) (ARSN 096 451 393) is issued by Pinnacle Fund Services Limited ABN 29 082 494 371 AFSL 238 371 (“PFSL”) as responsible entity of the Funds and is prepared by Antipodes Partners Limited (ABN 29 602 042 035) (AFSL 481580) (“Antipodes”) as the investment manager of the Trust. PFSL is not licensed to provide financial product advice.
The information provided is of a general nature only and has been prepared without taking into account your objectives, financial situation or needs. Before making an investment decision in respect of the Funds, you should consider the current Product Disclosure Statement (‘PDS’) and Target Market Determination (‘TMD’) of the Funds and the Fund’s other periodic and continuous disclosure announcements lodged with the ASX, which are available at www.asx.com.au, and assess whether the Fund is appropriate given your objectives, financial situation or needs. If you require advice that takes into account your personal circumstances, you should consult a licensed or authorised financial adviser. The Product Disclosure Statement (‘PDS’) and Target Market Determination (‘TMD’) of the relevant Fund are available via below links. Any potential investor should consider the PDS and TMD before deciding whether to acquire, or continue to hold units in, the Fund.
Links to Product Disclosure Statement: IOF0045AU, WHT0057AU, IOF0203AU, WHT3997AU
Links to Target Market Determination: IOF0045AU, WHT0057AU, IOF0203AU, WHT3997AU
For historic TMD’s please contact Pinnacle client service Phone 1300 010 311 or Email service@pinnacleinvestment.com
Neither PFSL nor Antipodes guarantees repayment of capital or any particular rate of return from the Funds. Neither PFSL nor Antipodes gives any representation or warranty as to the currency, reliability, completeness or accuracy of the information contained in this content. All opinions and estimates included in this website constitute judgments of Antipodes as at the date of website creation and are subject to change without notice. Past performance is not a reliable indicator of future performance.

Share:

More Posts

Now available on the ASX: the Antipodes Global SMID Active ETF (ASX:MIDS)

X